PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: air traffic controller

Clinical study protocol template

← Back to document page

Global Clinical Development - General Medicine QAW039/fevipiprantClinical Trial protocol CQAW039A2316 / NCT03215758A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthmaDocument type: Clinical Trial ProtocolEUDRACT number:2017-001273-16Version number:00 (OriginalProtocol) Clinical trial phase:IIIRelease date:10- May-2017Property of NovartisConfidentialMay not be used, divulged, published, or otherwise disclosedwithout the consent of NovartisClinical Trial protocol template Version (July 2016)NovartisConfidentialPage 2Clinical Trial protocol (Version 00) protocol No.

without the consent of Novartis Clinical Trial Protocol Template Version 3.2 (July 2016) Novartis Confidential Page 2 Clinical Trial Protocol (Version 00) Protocol No. CQAW039A2316 ... ATS/ERS American Thoracic Society/European Respiratory Society AV atrioventricular BMI body mass index BTPS body temperature and pressure saturated

  American, Novartis

Download Clinical study protocol template

DOWNLOAD

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Documents from same domain

New antibiotic treatment options for uncomplicated ...

clinicaltrials.gov

treatment options for gonorrhoea and only a few new drugs in the development pipeline, it is important to test existing antibiotics for their efficacy in gonorrhoea treatment. Objective : This project aims to identify new treatment modalities for uncomplicated gonorrhoea using

  Gonorrhoea

A PROSPECTIVE MULTI CENTER RANDOMIZED CONTROLLED …

clinicaltrials.gov

conjunction with Ceramic on Ceramic and Taperloc Complete Microplastyarticulation stem in primary total hip arthroplasty compared to patients who received the Exceed ABT Acetabular system with the same combination.

  System, Complete, Taperloc, Taperloc complete

Title: A Phase 1, Randomized, Double-Blind, Placebo ...

clinicaltrials.gov

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single and Multiple Doses of TAK-653 in Healthy Subjects Phase 1 TAK-653 Escalating Single and Multiple Dose Study in Healthy Subjects Sponsor: Takeda Development Centre Europe Ltd. 61 Aldwych London, WC2B 4AE United Kingdom

  Controlled, Double, Blind, Placebo, Randomized, Double blind, Placebo controlled

Statistical Analysis Plan (SAP) - ClinicalTrials.gov

clinicaltrials.gov

statistical analysis. The subsections below will describe analyses in addition to the descriptive statistics. 6.1 Primary outcome The primary analysis will compare intervention groups (water supplementation vs control treatment) on their mean change in fasting plasma glucose between baseline and 12 months using a linear mixed model.

  Analysis

A Phase II, Randomized, Double -blind, Placebo -controlled ...

clinicaltrials.gov

• International Conference on Harmonisation, E6 Good Clinical Practice: Consolidated Guideline. • All applicable laws and regulations, including, without limitation, data privacy laws and regulations. • Regulatory requirements for reporting serious …

  Good, Practices, Clinical, Good clinical practice

Clinical Study Report (CSR) Template (Drug and Device)

clinicaltrials.gov

ATC Anatomical Therapeutic Chemical CFB change from baseline DHA dapsone hydroxylamine eCRF electronic case report form IGA Investigator’s Global Assessment MedDRA Medication Dictionary for Regulatory Activities mITT modified intent-to-treat NAD N-acetyl dapsone PK pharmacokinetic ...

  Chemical, Therapeutic, Anatomical, Anatomical therapeutic chemical

Research Proposal - ClinicalTrials.gov

clinicaltrials.gov

as fecal microbiota transplantation (FMT). 4. Procedures Tissue samples will be obtained from consenting patients at (SDMCUT), or other relevant facilities (see section 6.i below), in accordance with protocols approved by the University of Texas Institutional Review Board (UTIRB). Patients who meet eligibility criteria will have their

  Research, Proposal, Fecal, Microbiota, Transplantation, Research proposals, Fecal microbiota transplantation

Novartis CSR template

clinicaltrials.gov

9.1 Study design Figure 9-1 Study design BID: twice a day, QD: once a day. This was a multicenter, randomized, double-masked, two-arm, placebo-controlled, parallel-group study in patients with normal tension glaucoma who were insufficiently controlled on travoprost 0.004% (Travatan) monotherapy. Approximately 200 patients were planned to be

  Design, Study, Parallel, Study design

DETAILED STATISTICAL ANALYSIS PLAN (SAP)

clinicaltrials.gov

Statistical principles : 4.1. Multiplicity : The diagnostic and prognostic basic stud y and each sub -study consist of one primary outcome and one or more secondary, exploratory outcomes. We will encounter multiplicity issues due to the multiple

  Principles, Statistical, Statistical principles

Title: TWILIGHT Study - Ticagrelor With Aspirin or Alone ...

clinicaltrials.gov

Prior stroke Dialysis-dependent renal failure Active bleeding or extreme-risk for major bleeding (e.g. acute ... Life expectancy < 1 year ... 7.3.4 Adverse Events based on signs and symptoms ...

  Based, Life, Stroke, Life expectancy, Expectancy

Related documents

American Association of Oral and Maxillofacial Surgeons ...

www.aae.org

In September 2004, Novartis, the manufacturer of the IV bisphosphonates pamidronate (Aredia ® ) and zoledronic acid (Zometa ®), notified healthcare professionals of additions to the labeling of these products, which provided cautionary language related to the development of osteonecrosis of the jaws. 33. This

  American, Novartis

PRACTICE GUIDELINE FOR THE Treatment of Patients With ...

psychiatryonline.org

ceiving royalties from American Psychiatric Publishing, Inc. (2005–2010), Basic Books (2005–2010), Elsevier (2005– 2010), and Oxford University Press (2007–2010). Dr. Rosenbaum reports attending advisory boards for Bristol-Myers Squibb, Cephalon, Cyberonics, Forest Phar-maceuticals, Inc., Eli Lilly and Company, MedAvante,

  American, Treatment

Seventh Report of the Joint National Committee on ...

www.nhlbi.nih.gov

Ayerst, Sankyo, Solvay, and Texas Biotechnology Corporation; she has served as a consultant/advi-sor for Bristol-Myers Squibb, Merck, Pfizer, Sanofi, Novartis, The …

  Novartis

Can Topical and Oral NSAIDs Be Combined for Pain Relief?

accurateclinic.com

Apr 18, 2016 · 10. Voltaren Gel® [package insert]. Parsippany, NJ: Novartis Consumer Health, Inc.; 2014. Simon LS, Grierson LM, Naseer Z, Bookman AAM, Zev Shainhouse J. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain. 2009;143 ...

  Novartis

AARC Clinical Practice Guideline: Effectiveness of ...

www.aarc.org

American Association for Respiratory Care, 9425 N MacArthur Boule-vard, Suite 100, Irving TX 75063. E-mail: shawna.strickland@aarc.org. DOI: 10.4187/respcare.02925 RESPIRATORY CARE • DECEMBER 2013 VOL 58 NO 12 2187

  American

Primary Biliary Cholangitis: 2018 Practice Guidance from ...

www.aasld.org

Guidance from the American Association for the Study of Liver Diseases Keith D. Lindor,1 Christopher L. Bowlus,2 James Boyer,3 Cynthia Levy,4 and Marlyn Mayo5 Preamble This American Association for the Study of Liver Diseases (AASLD) 2018 Practice Guidance on Primary Biliary Cholangitis (PBC) is an update of the PBC guidelines published in 2009 ...

  American, Study, Practices, Guidance, Primary, 2018, Association, Biliary, Cholangitis, Primary biliary cholangitis, 2018 practice guidance, American association for the study

Related search queries

American, Novartis, Treatment, Primary Biliary Cholangitis: 2018 Practice Guidance, American Association for the Study